Amvis Holdings, Inc.
Ambis Holdings Co., Ltd. Financial Summary for the Second Quarter of Fiscal Year ending September 2026 | May 14, 2026
Consolidated results for the second quarter of fiscal year ending September 2026 show net sales of approximately 25,600 million yen, operating profit of approximately 2,800 million yen, and net income of approximately 1,900 million yen, all increasing YoY. Segments such as the Medical Care Facility Business and Comprehensive Medical Support Business performed well.
Key Figures
- Net Sales: 25,600 million yen (YoY +7.5%)
- Operating Profit: 2,804 million yen (YoY +25.1%)
- Net Income: 1,896 million yen (YoY +29.5%)
AI要約
Overview of Results
Ambis Holdings Co., Ltd. recorded net sales of approximately 25,600 million yen, operating profit of approximately 2,800 million yen, and net income of approximately 1,900 million yen for the second quarter of fiscal year ending September 2026, significantly increasing compared to the same period last year. The Medical Care Facility Business and the Comprehensive Medical Support Business performed well; notably, the Medical Care Facility Business's net sales increased by 6.1% to approximately 25,033 million yen, with profits also growing substantially. The company is recovering from the impact of the COVID-19 pandemic and plans to continue active business expansion.
Outlook and Impact on Shareholders
Full-year projections estimate net sales of approximately 51,700 million yen, operating profit of about 3,800 million yen, and net income of roughly 2,700 million yen, reflecting expected increases in both sales and profits compared to the previous period. The company plans to enhance profitability through expansion of healthcare support services and new business development. Shareholder return strategies such as increased dividends and share buybacks are also being considered, ensuring continued attractive corporate management for investors.
Revenue Trend
Operating Profit Trend
Net Income Trend
Ambis Holdings Co., Ltd.
Company overview · Stock price · Financial data · All IR